Silex Systems (ASX: SLX) Surges 13.5% as Iran Tensions Revive Nuclear Energy: Buy Now or Wait for a Pullback?

Silex gains on nuclear demand, but risks remain

Silex Systems (ASX: SLX) surged 13.5% to A$5.55 earlier this week as escalating tensions in the Middle East pushed investors towards nuclear energy and fuel security stocks. The Iran conflict reminded markets just how vulnerable the West remains when it comes to uranium enrichment supply, and Silex is one of the very few ASX-listed companies sitting right at the centre of that problem. That pullback investors were waiting for has now arrived, with the stock retreating to A$5.27 at Friday’s close. But before buying the dip, investors should note one important reference point: a company director sold shares via a block trade at A$6.63 just weeks ago. At Friday’s close, SLX still sits nearly 20% below that exit level.

What are the Best ASX Energy Stocks to invest in right now?

Check our buy/sell tips

Why the Iran War Has Put Silex’s Laser Enrichment Technology Back in the Spotlight

Silex is not a uranium miner. It is the developer of SILEX laser isotope separation technology, a next-generation approach to uranium enrichment that uses lasers rather than the centrifuges that dominate the industry today. The commercial vehicle for this technology is the Global Laser Enrichment (GLE) joint venture, which Silex operates alongside Cameco (the global uranium giant). Silex holds a 51% stake in GLE, which is the only commercial-scale laser enrichment program advancing in the Western world.

The structural case here is strong. Russia’s Rosatom currently controls roughly 40% of global uranium enrichment capacity. Since the invasion of Ukraine, Western governments have been working urgently to reduce that dependence and rebuild independent enrichment supply chains. GLE achieved Technology Readiness Level 6 validation in October 2025, a significant milestone confirming that the technology works at a demonstrable scale.

The Iran conflict did not create this opportunity. What it did was remind investors that the opportunity exists. We believe the nuclear fuel security tailwind is genuine and that GLE’s recent milestones have meaningfully reduced execution risk.

Silex Positions for a Multi-Billion Dollar Market, and Government Is Now Backing Them

This week, GLE announced a US$98.9 million incentives package from the Commonwealth of Kentucky and McCracken County for the planned Paducah Laser Enrichment Facility, a US$1.76 billion project expected to create 240 high-wage jobs. That is concrete government financial support arriving right now, not in three years, and it meaningfully strengthens the commercial case for the Paducah facility.

That said, investors need to remain clear-eyed. Silex runs a licensing model, which means low capital requirements and potentially strong margins once GLE reaches commercial scale. But the company is currently operating at a loss, and profitability is not expected for at least three years. Revenue remains dependent on GLE successfully reaching commercial operation. The director’s block trade at A$6.63 does not mean the company is in trouble, but it does tell you insiders were comfortable taking money off the table well above where the stock trades today.

The Investor’s Takeaway

The nuclear fuel security thesis behind Silex is real, and the recent US$98.9 million Kentucky incentives announcement directly reduces the commercialisation risk that has weighed on the stock. For investors with a three to five-year horizon and a genuine tolerance for pre-revenue technology risk, the long-term case is compelling.

With the stock already retreating to A$5.27 at Friday’s close, the pullback is underway. In our view, a further softening towards A$4.80 to A$5.00 would represent the most considered entry point for speculative investors who believe in the nuclear enrichment story and are prepared to wait for GLE’s commercial decision.